Pseudomembranous colitis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25769243)

Published in Dis Mon on March 11, 2015

Authors

Priya D Farooq1, Nathalie H Urrunaga1, Derek M Tang1, Erik C von Rosenvinge1

Author Affiliations

1: University of Maryland Medical Center (Department of Medicine, Division of Gastroenterology and Hepatology), Baltimore, Maryland; National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases), Bethesda, Maryland; Veterans Affairs Maryland Health Center System (Veterans Affairs), Baltimore, Maryland.

Articles citing this

Role of ultrasound in colorectal diseases. World J Gastroenterol (2016) 0.75

Articles cited by this

(truncated to the top 100)

Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72

Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99

Clostridium difficile--more difficult than ever. N Engl J Med (2008) 12.12

Human schistosomiasis. Lancet (2006) 10.87

Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med (2011) 10.29

Clostridium difficile colitis. N Engl J Med (1994) 9.31

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis (2007) 8.65

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81

Amoebiasis. Lancet (2003) 6.90

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol (2012) 6.37

Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69

Amebiasis. N Engl J Med (2003) 5.63

Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49

The role of toxin A and toxin B in Clostridium difficile infection. Nature (2010) 5.32

'Collagenous colitis' with watery diarrhoea--a new entity? Pathol Eur (1976) 4.95

Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol (2013) 4.46

Gastrointestinal cytomegalovirus disease. Ann Intern Med (1993) 4.35

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis (2011) 4.09

Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis (2008) 4.07

Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis (1995) 4.06

Diagnosis and treatment of Clostridium difficile colitis. JAMA (1993) 3.97

Pseudomembranous colitis. J Clin Pathol (1977) 3.93

Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol (2011) 3.81

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis (2012) 3.71

Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 3.70

Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis (2008) 3.32

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol (2002) 3.24

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg (2007) 3.08

Reversible vascular occlusion of the colon. Surg Gynecol Obstet (1963) 3.07

AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology (2000) 3.01

Salmonella, the host and disease: a brief review. Immunol Cell Biol (2006) 2.95

Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol (2010) 2.93

Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci (2005) 2.87

Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther (2004) 2.83

Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79

Chronic diarrhea of unknown origin. Gastroenterology (1980) 2.69

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis (1997) 2.53

Clostridium difficile--Associated diarrhea: A review. Arch Intern Med (2001) 2.50

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect (2009) 2.33

Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med (2006) 2.33

Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol (2008) 2.22

Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15

Treatment of Clostridium difficile infection. Clin Infect Dis (2008) 2.13

Escherichia coli O157:H7 infection in humans. Ann Intern Med (1995) 2.12

Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis (2003) 2.09

Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med (2011) 1.98

Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97

The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis (2006) 1.95

Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol (2011) 1.94

Ischemic colitis. Dis Colon Rectum (1996) 1.94

Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother (2007) 1.92

Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85

Systematic review: microscopic colitis. Aliment Pharmacol Ther (2006) 1.81

Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis (2011) 1.79

Ischemic colitis: spectrum of disease and outcome. Surgery (2003) 1.78

Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol (1993) 1.77

Ischemic colitis during treatment with alosetron. Gastroenterology (2001) 1.74

Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr (1991) 1.72

Staphylococcal enterocolitis following antibiotic therapy. Ann Surg (1963) 1.71

Microscopic colitis. Gastroenterology (2011) 1.66

Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol (2000) 1.63

Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans. Rev Infect Dis (1988) 1.63

Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis (2010) 1.60

Can ischemic colitis be differentiated from C difficile colitis in biopsy specimens? Am J Surg Pathol (1997) 1.60

Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59

Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases. Clin Infect Dis (2004) 1.58

Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis (2013) 1.57

Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci (1990) 1.56

Microscopic colitis: a review. Am J Gastroenterol (2002) 1.53

Clostridium difficile: progress and challenges. Ann N Y Acad Sci (2010) 1.49

Pseudomembranous colitis with Escherichia coli O157:H7. J Pediatr Gastroenterol Nutr (1997) 1.47

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis (2012) 1.47

Pathogenesis of enteric Salmonella infections. Curr Opin Gastroenterol (2008) 1.46

Ischemic colitis has a worse prognosis when isolated to the right side of the colon. Am J Gastroenterol (2007) 1.45

Update on Clostridium difficile associated disease. Curr Opin Gastroenterol (2007) 1.44

Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases. Dig Dis Sci (2008) 1.43

Diagnosis of cytomegalovirus infection. Rev Infect Dis (1988) 1.35

Pseudomembranous colitis: causes and cures. Digestion (1999) 1.35

Colonic ischemia. J Clin Gastroenterol (1998) 1.33

Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy? AJR Am J Roentgenol (2001) 1.33

Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol (2004) 1.33

Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33

Ischemic colitis: CT evaluation of 54 cases. Radiology (1999) 1.33

Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum (2004) 1.31

The pathogenicity of Clostridium difficile. Clin Microbiol Infect (2001) 1.30

Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet (1986) 1.26

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study. J Infect Dis (1993) 1.24

The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol (1990) 1.22

The spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc (2004) 1.20

Entamoeba histolytica: an update. Curr Opin Infect Dis (2003) 1.19

Cytomegalovirus colitis in immunocompetent patients: a clinical and endoscopic study. Hepatogastroenterology (2012) 1.18

Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea. J Clin Microbiol (1989) 1.18

Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther (2006) 1.18

Ischemic colitis. Am J Surg (2006) 1.17

Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol (2005) 1.17

The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol (2000) 1.16